Andy Hahn: Check out our editorial on CV risk in men with prostate cancer treated with ADT

Andy Hahn, Genitourinary Medical Oncologist at MD Anderson Cancer Centre, shared on X:

“Check out our editorial on CV risk in men with prostate cancer treated with ADT.

We discuss the need to develop risk models specific to men with PCa and to better understand the biologic determinants of toxicity.”

Source: Andy Hahn/X